GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Book Value per Share

Vitrolife AB (OSTO:VITR) Book Value per Share : kr96.90 (As of Mar. 2025)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Book Value per Share?

Vitrolife AB's book value per share for the quarter that ended in Mar. 2025 was kr96.90.

During the past 12 months, Vitrolife AB's average Book Value Per Share Growth Rate was -0.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -3.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 49.20% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 39.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vitrolife AB was 101.90% per year. The lowest was -4.20% per year. And the median was 17.30% per year.

Vitrolife AB's current price is kr154.70. Its book value per share for the quarter that ended in Mar. 2025 was kr96.90. Hence, today's PB Ratio of Vitrolife AB is 1.60.

During the past 13 years, the highest P/B Ratio of Vitrolife AB was 26.30. The lowest was 0.99. And the median was 9.64.

Good Sign:

Vitrolife AB stock PB Ratio (=1.6) is close to 1-year low of 1.55.


Vitrolife AB Book Value per Share Historical Data

The historical data trend for Vitrolife AB's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Book Value per Share Chart

Vitrolife AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.54 113.12 123.56 93.93 100.70

Vitrolife AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.68 96.68 96.99 100.70 96.90

Competitive Comparison of Vitrolife AB's Book Value per Share

For the Medical Devices subindustry, Vitrolife AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's PB Ratio falls into.


;
;

Vitrolife AB Book Value per Share Calculation

Vitrolife AB's Book Value Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(13,639-0)/135
=100.70

Vitrolife AB's Book Value Per Share for the quarter that ended in Mar. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(13,125-0)/135
=96.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Vitrolife AB  (OSTO:VITR) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Vitrolife AB Book Value per Share Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines